HoxB7 is one of the 39 mammalian Hox genes that play essential roles in patterning the anterior-posterior body axis during development. There are small molecules that can regulate the expression or function of HOX genes. There are molecules known to target HOX genes or associated pathways. Some of these may influence HoxB7 directly or indirectly. These genes are integral to the establishment of body plans and are known for their homeobox domain, which allows them to bind to specific DNA sequences to regulate gene expression. HoxB7 is one such gene, and like its counterparts, it is pivotal in orchestrating the developmental blueprint, especially in the formation of particular segments of the body. Consequently, any aberrations in HoxB7 can lead to developmental anomalies.
HoxB7 Inhibitors specifically target either the gene's expression or its product's function. The action mechanism can vary widely among different inhibitors. Some may target the transcriptional machinery directly, the expression of the HoxB7 gene. Others might focus on the post-transcriptional modifications, ensuring that the HoxB7 protein doesn't achieve its active conformation. Yet, some inhibitors can interfere with the binding of HoxB7 to its target DNA sequences or disrupt its interaction with co-factors necessary for its function. Given the intricate regulation and importance of Hox genes in development, the design, and specificity of HoxB7 inhibitors is of utmost importance. Understanding the precise molecular mechanics behind these inhibitors can provide valuable insights into the broader Hox regulatory network and developmental biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
A derivative of vitamin A and has been used ATRA can induce differentiation and apoptosis in certain cells and has been shown to regulate HOX gene expression. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
An inhibitor of the Hedgehog signaling pathway, which is known to influence HOX gene expression during development. However, its effect might be more indirect. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitors. Epigenetic modifications, like DNA methylation, play a role in regulating HOX gene expression. By altering methylation patterns, these drugs might influence HoxB7 expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
DNA methyltransferase inhibitors. Epigenetic modifications, like DNA methylation, play a role in regulating HOX gene expression. By altering methylation patterns, these drugs might influence HoxB7 expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Can influence gene expression by altering chromatin structure. Since HOX genes are regulated by chromatin modifications, HDACi can potentially influence their expression. | ||||||
3-Deazaneplanocin, HCl salt | 120964-45-6 | sc-351856 sc-351856A sc-351856B | 1 mg 5 mg 10 mg | $251.00 $600.00 $918.00 | 2 | |
An inhibitor of the histone methyltransferase EZH2, which is part of the Polycomb Repressive Complex 2 (PRC2). PRC2 can methylate histones to suppress HOX genes, so DZNep might indirectly upregulate HoxB7 by inhibiting PRC2. | ||||||